drugset / Trial / NCT04493554

The Effects of Vasopressin on Attention Control

NCT04493554

RandomizedParallel-groupTriple-blindBasic science

Summary

The main aim of the present study is to investigate whether intranasal vasopressin (20IU) could influence attention control in a social-emotional saccade/antisaccade eye-tracking paradigm.

Timeline

Start
2020-07-28
Primary completion
2020-11-30
Completion
2021-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Vasopressin Peptide 20 iu Intranasal

Indications

No indication recorded.